HB 3167 West Virginia House of Delegates · 2025 Regular Session

To require hair follicle drug testing of parents or guardians in cases of substantiated child abuse or neglect of a minor

HB 3167 requires circuit courts in West Virginia to order 12-panel hair follicle drug testing for parents or guardians in cases where child abuse or neglect has been substantiated. The test covers drug use over the past 90 days and applies to all respondents, with additional requirements for infants under two months old if a parent tests positive. Attempts to alter hair (e.g., dyeing, shaving) or failure to comply with the court order are treated as positive test results. Test results may be shared with a multidisciplinary treatment team to inform child welfare decisions.
Bill status passed 3 of 5 stages cleared
Introduction
Mar 2025
Committee Review
Apr 2025
House of Delegates Passage
Mar 2025
Senate Passage
Governor
Introduced Mar 5, 2025 Last action Apr 9, 2025
Maddy AI version diff · 4 comparisons

What changed between versions

hb3167 hfa williams 3-28 adopted.htm hb3167 hfat akers 3-31 adopted.htm · 5 edits
MODERATE
The bill was amended to replace Delegate Williams' proposed addition of a hair follicle drug test rebuttal option with Delegate Akers' comprehensive amendment that rewrites the bill's title and scope. The new version expands the bill's language to include multiple provisions about drug testing, neurological evaluations for infants, and reporting procedures, while the original amendment only added a single rebuttal mechanism for drug allegations.
Scope change
The bill's scope was significantly expanded from a single rebuttal provision to include neurological evaluations for children under two months, multidisciplinary team reporting, and consequences for attempting to alter hair to evade drug detection.
SCOPE

The bill title was completely rewritten to reflect a broader scope including neurological evaluations, multidisciplinary team reporting, and consequences for tampering with hair samples, rather than just allowing drug test rebuttals.

REQUIREMENT

New requirement added allowing circuit courts to order pediatric neurological evaluations for children under two months of age in certain circumstances.

New provision allowing 12-panel hair follicle drug test results to be reported to multidisciplinary treatment teams, subject to circuit court limitations.

ENFORCEMENT

New provision establishing that attempting to alter hair to evade drug detection or refusing to take the test will be considered a positive drug test result.

ELIGIBILITY

The specific rebuttal provision allowing respondents to submit to hair follicle testing after an allegation but before filing a petition was removed from the bill's language.

Floor votes · House of Delegates Mar 31, 2025

How they voted

960
Passed · 4 other
Total votes 100
Mar 31, 2025
D Democratic9
8 Yea 1
88% Yea
R Republican91
88 Yea 3
96% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
23
Key actions
4
Committee
6
Amendments
1
Apr 9, 2025
Committee
On 2nd reading, rereferred to Judiciary
upper
Apr 9, 2025
Committee
Without recommendation, but first rereferred to Judiciary
upper
Apr 1, 2025
Committee
To Judiciary
upper
Apr 1, 2025
Introduced
Introduced in Senate
upper
Mar 31, 2025
Lower · Passed
Title amendment adopted (Voice vote)
lower
Mar 31, 2025
Lower · Passed
Passed House (Roll No. 281)
lower
Mar 28, 2025
Lower · Passed
Amendment adopted (Voice vote)
lower
Mar 28, 2025
Introduced
Amendment reported by the Clerk
lower
Mar 26, 2025
Lower · Passed
By substitute, do pass
lower
Mar 5, 2025
Committee
To House Judiciary
lower
Mar 5, 2025
Introduced
Introduced in House
lower
Mar 5, 2025
Committee
To Judiciary
lower
1 primary · 8 co-sponsors

Sponsors